Skip to main content

Table 2 Association of HERC4 expression with patient’s clinicopathological features in 120 invasive ductal carcinoma

From: The expression and clinical significance of HERC4 in breast cancer

Variables HERC4 staining
Negative(%) Positive(%) Total P valueb
Age(years)     
 ≤50a 25(45.5) 30(54.5) 55 0.927
 >50 29(44.6) 36(55.4) 65
pT status     
 T1 15(88.2) 2(11.8) 17 0.000
 T2 36(42.9) 48(57.1) 84
 T3 3(18.8) 16(81.2) 19
Lymph node metastasis     
 Negative 32(80) 8(20) 40 0.000
 Positive 22(27.5) 58(72.5) 80
Histology grade     
 I 41(95.3) 2(4.7) 43 0.000
 II 13(24.5) 40(75.5) 53
 III 0(0) 24(100) 24
Stage     
 I-II 43(76.8) 13(23.2) 56 0.000
 III-IV 11(17.2) 53(82.8) 64
ER status     
 Negative 25(43.1) 33(56.9) 58 0.686
 Positive 29(46.8) 33(53.2) 62
PR status     
 Negative 31(50) 31(50) 62 0.255
 Positive 23(39.7) 35(60.3) 58
HER2 status     
 Negative 15(42.9) 20(57.1) 35 0.762
 Positive 39(45.9) 46(54.1) 85
P53 status     
 Negative 23(41.8) 32(58.2) 55 0.519
 Positive 31(47.7) 34(52.3) 65
Ki67 status     
 Negative 15(38.5) 24(61.5) 39 0.318
 Positive 39(48.1) 42(51.9) 81
  1. a Mean age.
  2. b P value are from χ2-test.